Raloxifene Hydrochloride
- Product NDC
- 43353-253
- 11-digit product format
- 433530253
- Labeler code
- 43353
- Product ID
- 43353-253_293b1286-f467-418f-9b40-e5502c14c3b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Raloxifene Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA204310
- Marketing category
- ANDA
- Marketing start
- 2015-08-28
- Marketing end
- 0000-00-00
- Substance
- RALOXIFENE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-253 | RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20171005_786f2fa3-5a47-43a7-b4f5-fbb8f4de06fa.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-253-60 | 43353025360 | 90 TABLET, FILM COATED in 1 BOTTLE (43353-253-60) | 2016-11-15 | 0000-00-00 | No | No | Current |